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Definitions of severity and outcome measures 
C. E. BUCKNALL 
Greater Glasgow Health Board, Glasgow, Scotland, U.K. 
Outcome measurement is still a difficult area in general, and in asthma in particular, with further research 
needed. (Attributable) outcomes of health care are the only sort of outcome measure which are of direct use 
as a contracting tool. However, less well-researched and understood outcomes are useful as quality 
improvement tools, and within more open-ended discussions involving purchasers and providers. In terms of 
hospital care of acute asthma, there is no well-defined outcome measure which reflects the quality of hospital 
care; re-admission rates show promise as an outcome measure which relate to the quality of discharge 
planning and merit further study. In terms of ambulatory care, there is an urgent need to develop and evaluate 
a symptom-based outcome measure which would be usable in routine practice and could be recommended for 
widespread use. As a physiological outcome measure, percentage of best function is one which corrects for the 
degree of irreversible air flow obstruction and is independent of treatment step. It is valuable for individual 
patients by providing a realistic gold standard and, if best function is assessed in a standard manner, it also 
allows results of groups of patients to be compared in a meaningful manner. Severity scores, which might 
allow categorization of patients on the basis of characteristics other than current symptoms or therapy, are 
currently being evaluated. 
Introduction 
Busy clinicians may be right in thinking that 
outcome measurement is a current fashion which will 
go the way of all fashions with time. Certainly the 
measurement of outcome is not new - the standard 
data set recorded on all casualty attendances at the 
Royal Infirmary in Glasgow in the 18th century 
included a comment on whether the patient was 
relieved or unrelieved; and, in the late 19th century, 
Florence Nightingale also used this as a measure 
of outcome. There can be no doubt that there is 
currently interest in outcome measurement and it is 
worth considering why this should be so. 
Different professionals may see outcome measure- 
ment as, variously, a tool for purchasing, epidemio- 
logical surveillance, good clinical practice (perhaps 
better described as a goal - something to aim for, 
with the connotation of open discussion and agree- 
ment involving patients), or quality improvement. 
This final use is based on the premise that it may be 
more useful to investigate variations in outcome, 
rather than variations in practices of unknown 
relative merit. 
There are merits in each of these approaches, but 
they are different. Before reviewing the currently 
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available and potentially promising outcome 
measures in asthma, these different perspectives will 
be examined. 
Different Perspectives on Outcomes 
Different perspectives are worth considering, 
especially in view of the differing nature of data 
which may best be suited for different purposes. 
(1) 
(2) 
Purchasers would like to know about health care 
outcomes (1); these are results which can be 
causally related or attributed to the care given 
(see Table 1). Very few currently available 
outcomes fit this definition, but they are the 
most valid outcome indicators for contracting 
purposes since they reflect the processes being 
contracted for, rather than, for example, the 
population being served. 
Epidemiologists and the Government, through its 
Health of the Nation Initiative, are interested in 
improving health outcomes - results which are 
defined in terms of health, but with no causal 
attribution, e.g. a fall in the number of unwanted 
pregnancies or of suicides. In terms of asthma, 
the percentage of the population with diagnosed 
asthma is a health outcome, but this proportion 
may be influenced by a variety of possible 
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Table I Definitions of outcomes 
Definitions (1) 
An outcome: 
A health outcome: 
A health care outcome: 
A health outcome of health care: 
A result; an effect 
A result, defined in terms of health 
A result which is attributable or responsive 
to health care 
A result (defined in terms of health) which is 
attributable or responsive to health care 
environmental and socio-economic factors, as 
well as changes in current diagnostic practice. 
Therefore, it tells us relatively less about the 
quality of care. It follows from this that health 
outcomes are not only, or even primarily, 
the responsibility of health professionals or 
organizations (2). 
(3) Clinicians are primarily interested in 
outcomes-whether or not these are attribu- 
table to the process of care. They will take into 
account the different perceived needs of different 
patients on a more or less explicit basis, depend- 
ing on individual practice. They will recognize 
that a good outcome for one patient may be a 
poor one for the next - exercise-induced asthma 
may not be important for a teacher, but a disaster 
for the athlete. Therefore, this perspective recog- 
nizes that the definition of a good outcome will 
differ between patients. 
(4) The Colleges and Specialist Societies, and others, 
may identify outcome measurement as a short cut 
through the maze of (often unvalidated) vari- 
ations in practice recognized to be common 
throughout the practice of medicine. Therefore, 
this approach sees outcome measurement as a 
quality improvement tool, using variations in 
outcome, providing these can be measured in 
a valid way, as the starting point for further 
investigation of current practice. 
A final perspective in considering outcomes is that 
provided by time. An outcome may, at first glance, be 
a relatively clear-cut entity when, for example, a 
previously fit patient is subjected to an elective surgi- 
cal procedure. However, even then there is a need to 
define terms, time scales and follow-up. This has been 
well demonstrated in the area of wound infections, 
where it is now widely recognized that a high wound 
infection rate is as likely to signal assiduous data 
collection and follow-up as a major problem in 
surgical technique (3). For chronic conditions such as 
asthma, as well as the issues of rigour of follow-up 
and definitions, the fluctuating and long-term nature 
of the disease will present further problems in terms 
of definition of outcomes. 
What Outcome Measures do we Currently Have? 
HOSPITAL TREATMENT OF ASTHMA 
Deaths 
Deaths in hospital due to acute asthma are very 
rare (4) and have been shown to have only weak links 
with the process of care (5). Therefore, they can only 
be considered a crude measure of outcome. There 
is a large American literature on hospital-specific 
mortality rates (6) which suggests differences in 
mortality can have a large number of underlying 
causes. For asthma, the combination of small 
numbers of deaths and the confounding effects of 
differences in case mix, hospital/GP interface and 
subsequent management in primary care are likely to 
mitigate against such rates being a useful health care 
outcome measure, either for hospitals or primary 
care. 
Population-based admission rates 
It is possible, using routine data, to relate the 
number of hospital admissions to a given population. 
Practices which develop an interest in asthma will 
report anecdotally that hospital admissions have 
declined, but there is little published data on this (7). 
The relationship between admission rates and process 
of care are largely unexplored, although differences 
have been identified (8,9). Establishing causal rela- 
tions is likely to be difficult in view of the number of 
possible confounding factors, including deprivation, 
historical provision of acute beds, and differing 
management practices in primary care. As a quality 
improvement tool, this could be of value, indicating 
areas for more detailed review. 
Re-admission rates 
These are potentially more useful. Many studies 
have shown a relatively constant lo-20% 
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re-admission rate in adults (10-12). Improving the 
process of acute hospital care has been shown not to 
influence this rate (13), but that audit also showed 
that the process of discharge planning did not 
improve over the audit/re-audit cycle, suggesting 
the possibility that re-admission rates relate to the 
quality of care at the interface of hospital and GP 
services. Early results from a controlled study evalu- 
ating the impact of detailed discharge planning and 
close follow-up in childhood asthma have recently 
shown that re-admission rates are halved in the 
intervention group (14). Further work is needed, but 
this data would suggest that re-admission rates do 
reflect the process of care and, therefore, begin to fit 
the definition of a ‘health care outcome’. Percentage 
peak flow variability in the 24 h before discharge is, 
either as a proxy or a true outcome measure, worthy 
of further investigation. It has been shown to relate 
to re-admission (12,15), but may be influenced by 
‘patient’ factors as much or more than ‘treatment’ 
factors. 
Length of hospital stay 
It is arguable whether this is truly ‘a result or effect’ 
rather than a process measure. However, patients 
value early appropriate discharge, and hospital man- 
agers rightly point to the opportunity costs of unduly 
prolonged hospitalization. Wide variations in the 
process of asthma care in hospital have been docu- 
mented, including variations in the use and early use 
of corticosteroids (10-12). Whether closer attention 
to a good process of care has an impact on the length 
of hospital stay is worth further study. The British 
Thoracic Society (BTS) Audit Database (hospital 
management of acute severe asthma) (16) aims to 
facilitate local audit as a tool for quality improve- 
ment, and may also allow this question to be 
answered with time. 
AMBULATORY ASTHMA CARE 
Symptom scores 
Knowledge of current symptoms, preferably 
recorded in a standard manner, can be considered a 
health outcome measure, since symptoms are influ- 
enced not only by previous treatment, but also by 
other factors including compliance and patients’ per- 
ceptions of the relative claims of symptoms and 
treatment. It is unlikely that precise causal relation- 
ships with the process of care will be proved and, 
therefore, unlikely that such scores will be established 
as valid ‘health outcomes of health care’. They are 
likely to be of use mainly within the consultation, and 
as epidemiological and quality improvement tools. 
There are a number of well-validated symptom 
measures which have been developed as research 
(17-19) or audit (20) tools, but they are not appli- 
cable to everyday clinical practice. Other workers 
have developed shorter instruments for a variety of 
purposes including case finding (21,22), audit (23,24), 
and outcome measurement (25). None of these is in 
widespread use and, as such, can only be useful as a 
tool in local audit of practice. Therefore, further 
work is needed in this area if a valid and usable 
health outcome measure is to be developed. 
Current treatment 
This can be considered an outcome of previous 
consultations, but there are a number of confounding 
factors. One of these is doctor/patient interactions on 
the nature of acceptable treatment, and the trade-off 
which patients make between increasing treatment 
and the risk (or perceived risk) of side-effects and 
toleration of a degree of morbidity. Another con- 
founding factor is the problem associated with 
changes in prescribing practice over time. Thus, an 
audit cycle conducted in hospital before and after the 
introduction of Becloforte showed profound differ- 
ences in the use of this drug, but was unable to 
establish a relationship between use of Becloforte and 
severity of asthma (13). The introduction of the five 
BTS treatment steps may, at least in part, address this 
problem by categorizing different treatments on an 
escalating scale into which future new drug therapy 
can be slotted. Anecdotal data (Mike Pearson, pers. 
comm.), categorizing patients in primary care and 
hospital asthma clinics by treatment steps, has shown 
that those in hospital follow-up were on the higher 
BTS treatment steps, providing some support for the 
view that such patients have more severe asthma. In 
summary, current treatment may be an outcome/ 
health outcome, but not one ever likely to be related 
causally to the process of care alone. 
Practice- or practitioner-based admission rates 
As noted earlier, general practitioners with a devel- 
oping interest in asthma will report anecdotally that 
with developing interest in asthma management, the 
number of emergency hospital admissions with acute 
asthma has diminished. Some systematic data on this 
is now emerging (7) and, since admission rates by 
practice or general practitioner could be calculated 
from routine data, it may bear further investigation. 
There is evidence relating deprivation to admission 
rates (26) and this, as well as case mix,.are possible 
confounding variables which may limit the use of 
such a measure as a health care outcome. It may be 
of value as a quality improvement tool. 
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Physiological measurements 
Peak flow rate or spirometry expressed as a 
percentage of predicted are valuable if there is no 
fixed air flow obstruction, but many patients with 
asthma do develop this. Whether the development 
of irreversible air flow is affected by the quality of 
asthma control is unknown, and would require a 
very long-term study to evaluate. As a long-term 
outcome measure, therefore, percentage predicted 
PFR or FEV, can only be considered a health 
outcome. 
The problem of evaluating current lung function 
in a patient who has developed some irreversible 
air flow obstruction led to the investigation of other 
measures. Percentage of best function, where this 
is measured according to a defined protocol, looks 
promising as a more generally applicable health 
outcome measure (23). It provides a personal gold 
standard for an individual patient with mixed 
reversible/irreversible air flow obstruction, and 
should, therefore, be useful within the consultation. 
In patients with no irreversible air flow obstruction, 
best function and predicted function coincide. 
Therefore, this measure allows data from both 
types of patient to be amalgamated. In addition, 
‘percentage of best function’ is independent of 
current treatment step, which may itself be related 
to severity of asthma. Thus, within any group of 
patients on similar therapy, there will be a range of 
values for ‘percentage best function’ which they 
are currently achieving. Since the aim would be 
for patients to achieve as near 100% of best func- 
tion as possible, the measure allows inferences 
to be made about current therapy/supervision. 
Therefore, it is useful clinically, as well as pro- 
viding a quality improvement and epidemiological 
tool. 
A possible reservation about the use of ‘percent- 
age best function’ as an outcome measure is that, to 
remain valid, best function should be re-assessed 
from time to time. However, this revision may 
allow a decline in lung function to go unremarked. 
This difficulty could be addressed by expressing 
the change in best function over a period of 
time in millilitres or litres per year, and would 
arguably help to identify such patients more 
readily. 
Bronchial hyper-reactivity has not been shown to 
be influenced by treatment (27). Neither bronchial 
hyper-reactivity nor the degree of peak flow vari- 
ability can be considered outcome measures 
which are useful in routine practice (although PFR 
variability is undoubtedly a useful tool for assessing 
patients). 
Current ‘Best Buys’ as Outcome Measures for 
Asthma 
HOSPITAL CARE 
There is currently no good outcome measure which 
is known to relate to the quality of hospital care, 
rather than case mix. This reinforces the utility of 
review of the process of care concentrating on the 
delivery of known effective practices, for example 
using the BTS Audit Database (16) and giving con- 
sideration to changes in practice which improve the 
delivery of care. 
HOSPITALICP INTERFACE AFTER HOSPITAL ADMISSION 
In view of the recent findings described earlier, 
where re-admission rates fell in the face of 
good discharge planning and follow-up, this 
merits further evaluation as a health care outcome 
measure. 
AMBULATORY CARE 
There is an urgent need to identify a standard 
symptom score, building on existing work, in order to 
produce a tool which would both support good 
patient care and become a common currency for 
audit and quality improvement (28). This is particu- 
larly important in the face of the often arbitrary 
decisions on data sets for chronic disease manage- 
ment currently being used in primary care. 
In terms of physiological measures, for the 
reasons stated above, percentage of best function 
offers the best prospect of a valid physiological 
measure of outcome, and certainly merits further 
evaluation. 
Both of these measures will describe health out- 
comes which relate to patient as well as treatment 
factors and are, therefore, unlikely to be attributable 
to health care delivery alone. As valid health out- 
come measures, they would be of benefit to epidemi- 
ologists and clinicians, and as quality improvement 
tools. 
Severity Measures 
The need for a severity measure arises from a 
recognition of the long-term and fluctuating nature 
of asthma, and the utility of having different tools for 
measuring short-term asthma control and longer 
term overall severity. A valid measure of asthma 
severity would allow more accurate representation of 
case mix for epidemiological purposes and in the 
comparison of groups of patients in audit; it might 
also be a useful predictor of the need for services. 
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Factors which may be important in describing sever- 
ity include lung function, compliance, psychological 
adjustment and previous service use (e.g. hospital 
admission). Although there are methodological prob- 
lems in how any such measure might be validated, 
work on this is currently underway (A. Hutchinson, 
pers. comm.). 
Another approach to defining severity would be to 
build a multi-dimensional picture about the severity 
of asthma, whether for individual patients or groups, 
based on: 
(1) The current degree of symptom control (see 
above); 
(2) A physiological measurement which is indepen- 
dent of treatment step (see above); and 
(3) Current BTS treatment step (29). 
The relative merits of these two approaches have 
not been evaluated and both the concept of a severity 
measure and any practical tools arising from it are, 
therefore, currently areas for further research. 
Acknowledgements 
This paper presents the author’s views on the 
current state of severity and outcome measures, 
but these have been informed by discussions with 
colleagues in the Asthma Audit Sub-Committee of 
the BTS Standards of Care Committee, as well as 
elsewhere, and the author gratefully acknowledges 
their contribution. 
References 
1, Shanks J, Frater A. Health status, outcome and attrib- 
utability: is a red rose red in the dark. Qual Health Care 
1993; 2: 259-262. 
2. Gabbay J. The health of the nation. BMJ 1992; 305: 
129-130. 
3. Byrne DJ, Lynch W, Napier A, Davey P, Malek M, 
Cuschieri A. Wound infection rates: the importance 
of definition and post discharge wound surveillance. 
J How Infect 1994; 26: 3143. 
4. Mackay T, Wathen CG, Elton RA, Sudlow MF. Fac- 
tors affecting asthma mortality in Scotland. Scot A4ed J 
1992; 37: 5-7. 
5. Eason J, Markowe HLJ. Controlled investigation of 
deaths from asthma in hospitals in the North East 
Thames region. BMJ 1987; 294: 1255-1258. 
6. Fink A, Yano EM, Brook RH. The condition of the 
literature on differences in hospital mortality. Med Care 
1989; 27: 315-336. 
7. Price DB. Pattern of prescribing of inhaled steroids over 
a seven year period in a general practice, and its 
8. Hyndman SJ, Williams DRR, Merrill SL, Lipscombe 
JM, Palmer CR. Rates of admission to hospital for 
asthma. BMJ 1994; 308: 159661600. 
9. Bucknall CE, Kendrick S. Emergency admissions 
increasing in Scotland. BMJ 1994; 309: 604. 
10. Bucknall CE, Robertson C, Moran F, Stevenson RD. 
Differences in hospital asthma management. Lancet 
1988; i: 748-750. 
11. Bell D, Layton AJ, Gabbay J. Use of a guideline based 
questionnaire to audit hospital care of acute asthma. 
BA4J 1991; 302: 1440-1443. 
12. Pearson MG, Ryland I, Harrison BDW, on behalf of 
the Standards of Care Committee. National audit of 
acute severe asthma in adults admitted to hospital. Qua1 
Health Care 1995; 4: 24-30. 
13. Bucknall CE, Robertson C, Moran F, Stevenson RD. 
Improving management of asthma: closing the loop or 
progressing along the audit spiral? Qua1 Health Care 
1992; 1: 15-20. 
14. Madge P, Paton JY. The impact of structured, nurse led 
discharge planning on outcome in children hospitalised 
with acute asthma - a randomised controlled study 
(abstract). Thorax 1995; 50: 464P. 
15. Bucknall CE, Robertson C, Moran F. Stevenson RD. 
Why uncritical criterion based audit is not enough: 
analysis of PEF data from a prospective asthma audit 
(abstract). Thorax 1992; 47: 884. 
16. BTS Audit Database (Hospital Management of Acute 
Severe Asthma). Qua1 Health Care 1995; 4: 230: (see 
Appendix for further information). 
17. Guyatt GH, Berman LB, Townsend M, Pugsley SO, 
Chambers LW. A measure of quality of life for 
clinical trials in chronic lung disease. Thorax 1987; 42: 
773-778. 
18. Hyland ME, Finnis S, Irvine SH. A scale for assessing 
quality of life in adult asthma suffers. J Psychosom Res 
1991; 35: 99-l 10. 
19. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A 
self-complete measure for chronic airflow limitation - 
the St. George’s Respiratory Questionnaire. Am Rev 
Respir Dis 1992; 145: 132-137. 
20. McCall E, Steen IN, Hutchinson A et al. Developing 
outcome measures for asthma and diabetes. Sot Sci 
Med; in press. 
21. Jones KP, Bain DJG, Middleton M, Mullee MA. 
Correlates of asthma morbidity in primary care. BMJ 
1992; 304: 361-364. 
22. Jones KP, Charlton I, Middleton M, Preece W, Hill A. 
Targeting asthma care in general practice using a 
morbidity index. BA4J 1992; 304: 135-136. 
23. Connolly CK, Prescott RJ, Alcock SM, Gatnash AA. 
Actual over best function as an outcome measure’ in 
asthma. Respir Med 1994; 88: 453460. 
24. King R, Baldwin DR, Pantin CFA, Pathak UA. The 
reproducibility and validity of a written questionnaire 
based auditing system. Eur Respir J 1993; 6: (suppl 17): 
146s. 
25. Steen N, Hutchinson A, McCall E et al. Development 
of a symptom based outcome measure for asthma. BMJ 
1994; 30% 1065-1068. 
26. Watson JP, Cowan P, Lewis RA. Asthma and poverty 
in the West Midlands (abstract). Thorax 1995; 50: 463P. 
27. Cartier A, Malo JL. Role of non-allergenic bronchial 
implications (abstract). Thorax 1995; SU: 443P. hyper-reactivity follow-up studies in the assessment 
452 C. E. Bucknall 
of prognosis of asthma. Rev Mal Respir 1994; 11: Appendix 
209-215. 
28. Keeley D. How to achieve better outcome in the 
treatment of asthma in general practice. BMJ 1993; 307: Further details of the BTS Audit Database (hospi- 
1261-1263. tal management of acute severe asthma) from: Mrs 
29. The British Thoracic Society and Others. Guidelines for Ida Ryland, Asthma Audit Office, Aintree Chest 
the Management of Asthma. Thorax 1993; 48 (suppl): Centre, Fazakerley Hospital, Lower Lane, Liverpool 
S l-24. L9 7AL, U.K. 
